-transparent.png){kind=logo}
Immunosuppressive regimens, which include antithymocyte globulin (ATG), are widely used for the treatment of severe aplastic anemia (SAA). However, bradycardia has been reported only as a rare side effect of ATG therapy in the manufacturer's product information and, in rare cases, in the adult literature. We present an adolescent with SAA and preexisting bradycardia who underwent immunosuppression therapy with ATG, methylprednisolone, and tacrolimus and developed profound sinus bradycardia with successive doses of ATG.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Justin Godown, and
Allison M Deal, and
Kathy Riley, and
Frederique Bailliard, and
Julie Blatt
October 1982,
Experimental hematology,
Justin Godown, and
Allison M Deal, and
Kathy Riley, and
Frederique Bailliard, and
Julie Blatt
February 1986,
Harefuah,
Justin Godown, and
Allison M Deal, and
Kathy Riley, and
Frederique Bailliard, and
Julie Blatt
July 1983,
Lancet (London, England),
Justin Godown, and
Allison M Deal, and
Kathy Riley, and
Frederique Bailliard, and
Julie Blatt
February 2014,
Pediatric hematology and oncology,
Justin Godown, and
Allison M Deal, and
Kathy Riley, and
Frederique Bailliard, and
Julie Blatt
January 1990,
Harefuah,
Justin Godown, and
Allison M Deal, and
Kathy Riley, and
Frederique Bailliard, and
Julie Blatt
January 1988,
The Journal of rheumatology,
Justin Godown, and
Allison M Deal, and
Kathy Riley, and
Frederique Bailliard, and
Julie Blatt
August 1992,
Indian pediatrics,
Justin Godown, and
Allison M Deal, and
Kathy Riley, and
Frederique Bailliard, and
Julie Blatt
July 2015,
Korean journal of pediatrics,
Justin Godown, and
Allison M Deal, and
Kathy Riley, and
Frederique Bailliard, and
Julie Blatt
May 2014,
American journal of hematology,
Justin Godown, and
Allison M Deal, and
Kathy Riley, and
Frederique Bailliard, and
Julie Blatt
September 1983,
British journal of haematology,
